New Parkinson’s drug could slow or reverse progression of disease, researchers say: ‘Big step forward’ » Department of Neurology » College of Medicine » University of Florida

Power For Parkinson's on Instagram: "Exciting news! On Tuesday, the second under-the-skin infusion for Parkinson’s, Onapgo, Earned FDA Approval. Onapgo uses a continuous under-the-skin infusion to deliver apomorphine, a drug that helps control motor symptoms. This approval is based on the results of a clinical trial of 107 people with Parkinson’s. Study participants who received Onapgo experienced two hours less “off” time per day compared to participants who received a placebo. Onapgo is expect